Caren Deardorf's Insider Trades & SAST Disclosures

Caren Deardorf's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 10,350 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.

Share

Note

This is a custom search result for pattern Caren Deardorf.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2025	10,350	10,350	-		-	Stock Option (right to buy)
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2025	6,900	16,300 (0%)	0%		0	Common Stock
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2024	12,500	12,500	-		-	Stock Option (right to buy)
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2024	3,400	9,400 (0%)	0%		0	Common Stock
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2023	17,500	17,500	-		-	Stock Option (right to buy)
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2023	6,000	6,000 (0%)	0%		0	Common Stock
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	4,375	4,375	-		-	Stock Option (right to buy)
Crinetics Pharmaceuticals Inc	Caren Deardorf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2022	35,000	35,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades